Private Advisor Group, LLC Compugen LTD Transaction History

Private Advisor Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.68 - $1.11 $6,875 - $11,223	10,111 New	10,111 $7,000
Q4 2021 Feb 10, 2022	SELL	$4.09 - $7.16 $18,405 - $32,220	-4,500 Reduced 10.38%	38,850 $167,000
Q3 2021 Oct 14, 2021	BUY	$5.8 - $8.02 $8,700 - $12,030	1,500 Added 3.58%	43,350 $259,000
Q4 2020 Apr 01, 2021	SELL	$12.07 - $17.95 $12,070 - $17,950	-1,000 Reduced 2.33%	41,850 $507,000
Q3 2020 Nov 02, 2020	SELL	$14.16 - $19.45 $708 - $972	-50 Reduced 0.12%	42,850 $696,000
Q2 2020 Aug 17, 2020	BUY	$6.97 - $17.12 $31,365 - $77,040	4,500 Added 11.72%	42,900 $644,000
Q1 2020 May 12, 2020	SELL	$5.79 - $11.83 $22,627 - $46,231	-3,908 Reduced 9.24%	38,400 $279,000
Q4 2019 Feb 10, 2020	BUY	$3.9 - $6.16 $33,150 - $52,360	8,500 Added 25.14%	42,308 $252,000
Q1 2019 May 13, 2019	BUY	$2.35 - $4.19 $79,448 - $141,655	33,808 New	33,808 $140,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.